177Lu-OncoACP3

N/A

Report date: 2025/11/11 18:00:08
NME

Base Information

Drug Name177Lu-OncoACP3
Drug Alias Name177Lu-OncoACP3
ClassificationRadiation-emitting products > Radioactive therapeutic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Lutetium > 177Lu +[4] 
Mechanisms of ActionProstatic acid phosphatase modulatorsIonising radiation emitters
TargetsProstatic acid phosphatase
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhilochem AG
China Registration ClassN/A

Develop Information

Active CompaniesPhilochem AGRayzeBio IncBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A